federal_register: 2016-31437
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-31437 | Prospective Grant of Exclusive Patent License: Development and Commercialization of Nitrite Salts for the Treatment, Amelioration, and Prevention by Any Route of Administration of Pulmonary Hypertension, Including All WHO Classifications of Pulmonary Hypertension, e.g., Groups 1-5 | Notice | The National Heart, Lung, and Blood Institute ("NHLBI"), an institute of the National Institutes of Health; an agency within the Department of Health and Human Services, is contemplating the grant of an exclusive patent license to commercialize the invention(s) embodied in the intellectual property estate stated in the Summary Information section of this notice to United Therapeutics Corporation ("United") located in Silver Spring, MD and incorporated under the laws of Delaware. | 2016-12-29 | 2016 | 12 | https://www.federalregister.gov/documents/2016/12/29/2016-31437/prospective-grant-of-exclusive-patent-license-development-and-commercialization-of-nitrite-salts-for | https://www.govinfo.gov/content/pkg/FR-2016-12-29/pdf/2016-31437.pdf | Health and Human Services Department; National Institutes of Health | 221,353 | The National Heart, Lung, and Blood Institute ("NHLBI"), an institute of the National Institutes of Health; an agency within the Department of Health and Human Services, is contemplating the grant of an exclusive patent license to commercialize the... |